| Development of a ligand for in vivo imaging of mutant huntingtin in Huntington’s disease D Bertoglio, J Bard, M Hessmann, L Liu, A Gärtner, S De Lombaerde, ... Science translational medicine 14 (630), eabm3682, 2022 | 25 | 2022 |
| Altered basal forebrain function during whole-brain network activity at pre-and early-plaque stages of Alzheimer’s disease in TgF344-AD rats M van den Berg, MH Adhikari, M Verschuuren, I Pintelon, T Vasilkovska, ... Alzheimer's research & therapy 14 (1), 148, 2022 | 19 | 2022 |
| Resting-state fMRI reveals longitudinal alterations in brain network connectivity in the zQ175DN mouse model of Huntington's disease T Vasilkovska, MH Adhikari, J Van Audekerke, S Salajeghe, D Pustina, ... Neurobiology of Disease 181, 106095, 2023 | 10 | 2023 |
| Characterization of cell type-specific S100B expression in the mouse olfactory bulb X Su, T Vasilkovska, N Fröhlich, O Garaschuk Cell Calcium 94, 102334, 2021 | 7 | 2021 |
| Longitudinal investigation of changes in resting-state co-activation patterns and their predictive ability in the zQ175 DN mouse model of Huntington’s disease MH Adhikari, T Vasilkovska, R Cachope, H Tang, L Liu, GA Keliris, ... Scientific Reports 13 (1), 10194, 2023 | 3 | 2023 |
| A novel imaging ligand as a biomarker for mutant huntingtin-lowering in Huntington’s disease D Bertoglio, J Bard, M Hessmann, L Liu, A Gärtner, SD Lombaerde, ... BioRxiv, 2021.07. 09.451725, 2021 | 3 | 2021 |
| Altered Patterns of Neural Activity and Functional Connectivity Revealed by Dynamic rsfMRI in the Q175 Mouse Model of Huntington’s Disease T Vasilkovska, B Callewaert, S Salajeghe, D Pustina, L Liu, M Skinbjerg, ... Int. Soc. Magn. Reson. Med. Online Abstracts. Abstract, 2021 | 1 | 2021 |
| Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington’s disease T Vasilkovska, S Salajeghe, V Vanreusel, J Van Audekerke, ... Journal of biomedical science 31 (1), 37, 2024 | | 2024 |
| Evolution of aberrant brain-wide spatiotemporal dynamics of resting-state networks in a Huntington's disease mouse model T Vasilkovska, M Verschuuren, D Pustina, M van den Berg, ... bioRxiv, 2023.11. 20.567961, 2023 | | 2023 |
| On the hunt for a novel biomarker of Huntington’s disease: disentangling brain network activity from hemodynamic alterations across disease progression T Vasilkovska University of Antwerp, 2023 | | 2023 |
| Resting-State fMRI reveals Longitudinal Alterations in Brain Network Connectivity in a Mouse Model of Huntington’s Disease T Vasilkovska, MH Adhikari, J Van Audekerke, D Pustina, R Cachope, ... bioRxiv, 2022.11. 19.517166, 2022 | | 2022 |
| Longitudinal Evaluation Of The First Mutant Huntingtin PET Radioligand As A Marker For mHTT Lowering Therapies For Huntington's Disease D Bertoglio, J Verhaeghe, S De Lombaerde, F Zajicek, T Vasilkovska, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 48 (SUPPL 1 …, 2021 | | 2021 |
| Diffusion MRI reveals rescue of structural changes in a mouse model of Huntington’s disease by mutant Huntingtin lowering J van Rijswijk, N Vidas-Guscic, J Van Audekerke, T Vasilkovska, ... | | |
| Impact of early suppression of mutant Huntingtin in LacQ140 mouse model of Huntington’s disease on resting-state dynamics T Vasilkovska, MH Adhikari, J van Rijswijk, E Van Doninck, ... | | |
| Impaired brain perfusion and cerebrovascular reactivity in the zQ175 mouse model of Huntington’s Disease, a longitudinal pCASL-MRI study T Vasilkovska, V Vanreusel, S Salajeghe, J van Audekerke, L Hirschler, ... | | |
| In vivo Fixel-Based Analysis of diffusion MRI in manifested Huntington’s disease in the zQ175 HD model N Vidas-Guscic, J Van Audekerke, B Jeurissen, J Orije, T Vasilkovska, ... | | |
| Resting-state co-activation patterns (CAPs) accurately predict pre-and manifest-stage Huntington’s disease in mice. MH Adhikari, T Vasilkovska, D Pustina, L Liu, R Cachope, H Tang, ... | | |
